Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Xeris Biopharma Holdings, Inc.

NASDAQ: XERS · Life Sciences · 12 alerts · CIK 1867096

Share price
$16.70Close, Nov 16
Market cap
$3.05B
Shares outstanding
182.7MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Xeris Biopharma Holdings, Inc. filings on SEC EDGAR ↗

8:06 AM ET 8-K
Executive Compensation

Xeris Biopharma Holdings Executive Compensation

Xeris Biopharma Holdings appointed Menassie Taddese to its Board of Directors and Audit Committee, effective November 2, 2026. In connection with his appointment, Mr. Taddese received an initial equity award of options and RSUs with a grant date fair value of approximately $450,000 and will be eligible for annual equity grants of $300,000. Mr. Taddese brings nearly 30 years of experience from leadership roles at Viatris and Pfizer.

Counterparty
Menassie Taddese

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.